A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions

NCT03017014 · clinicaltrials.gov ↗
TERMINATED
Status
62
Enrollment
INDUSTRY
Sponsor class

Stopped Low enrollment

Conditions

Sponsor

AbbVie